XML 18 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements Of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash Flows from Operating Activities    
Net (loss)/income $ 281 $ (682)
Income/(Loss) from discontinued operations, net of income tax (320) (798)
Income from Continuing Operations 601 116
Adjustments to reconcile net income to net cash provided by operating activities:    
Distributions and equity in earnings of unconsolidated affiliates 10 0
Depreciation, amortization and accretion 403 490
Provision for bad debts 57 57
Amortization of nuclear fuel 38 37
Amortization of financing costs and debt discount/premiums 21 15
Adjustment for debt extinguishment 22 3
Amortization of intangibles and out-of-market contracts 21 79
Amortization of unearned equity compensation 36 27
Impairment losses 89 60
Changes in deferred income taxes and liability for uncertain tax benefits (6) (1)
Changes in nuclear decommissioning trust liability 50 20
Changes in derivative instruments (17) 36
Changes in collateral deposits in support of energy risk management activities (30) (103)
Gain on sale of emission allowances (20) 21
Gain on sale of assets (30) (4)
GenOn settlement in July 2018 (125) 0
Loss on deconsolidation of business 13 0
Changes in other working capital (375) (295)
Cash provided/(used) by continuing operations 758 558
Cash provided by discontinued operations 324 178
Net Cash Provided/(Used) by Operating Activities 1,082 736
Cash Flows from Investing Activities    
Acquisitions of businesses, net of cash acquired (209) (12)
Capital expenditures (345) (172)
Purchases of emission allowances (30) (47)
Proceeds from sale of emission allowances 54 104
Investments in nuclear decommissioning trust fund securities (449) (402)
Proceeds from the sale of nuclear decommissioning trust fund securities 398 382
Proceeds from sale of assets, net of cash disposed and sale of discontinued operations, net of fees 1,555 309
Deconsolidation of business (268) 0
Changes in investments in unconsolidated affiliates (62) 24
Other 0 30
Cash (used)/provided by continuing operations 644 216
Cash used by discontinued operations (703) (638)
Net Cash (Used)/Provided by Investing Activities (59) (422)
Cash Flows from Financing Activities    
Payment of dividends to common stockholders (28) (28)
Payment for treasury stock (1,000) 0
Proceeds from issuance of long-term debt 995 308
Payments for short and long-term debt (970) (343)
Receivable from affiliate (26) (125)
Net distributions to noncontrolling interests from subsidiaries (17) (18)
Payment of debt issuance costs (19) (39)
Other (4) (8)
Cash provided/(used) by continuing operations (1,069) (253)
Cash provided by discontinued operations 403 39
Net Cash Provided/(Used) by Financing Activities (666) (214)
Effect of exchange rate changes on cash and cash equivalents 1 (10)
Change in Cash from discontinued operations 24 (421)
Net Increase in Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash 334 511
Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash at Beginning of Period 1,083 860
Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash at End of Period $ 1,417 $ 1,371